| 751688 |
FRONTIERS IN ONCOLOGY |
Detailed Analysis and Radiomic Prediction of First Progression Sites of First-Line Targeted Therapy for EGFR-Mutant Lung Adenocarcinoma Patients With Systemic Metastasis |
2021-10-05 |
10.3389/fonc.2021.757892 |
Li Xiaoyang, Hou Runping, Yu Wen, Zhu Xueru, Li Hongwei, Yang Yidong, Qian Dong, Fu Xiaolong |
| 751687 |
FRONTIERS IN ONCOLOGY |
Commentary: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma |
2021-10-05 |
10.3389/fonc.2021.730782 |
Temiz Mustafa Zafer |
| 751686 |
FRONTIERS IN ONCOLOGY |
A Nomogram for Predicting Pathological Complete Response to Neoadjuvant Chemoradiotherapy Using Semiquantitative Parameters Derived From Sequential PET/CT in Locally Advanced Rectal Cancer |
2021-10-05 |
10.3389/fonc.2021.742728 |
Pyo Dae Hee, Choi Joon Young, Lee Woo Yong, Yun Seong Hyeon, Kim Hee Cheol, Huh Jung Wook, Park Yoon Ah, Shin Jung Kyong, Cho Yong Beom |
| 751685 |
FRONTIERS IN ONCOLOGY |
Arsenic Trioxide Promotes Tumor Progression by Inducing the Formation of PGCCs and Embryonic Hemoglobin in Colon Cancer Cells |
2021-10-05 |
10.3389/fonc.2021.720814 |
Li Zugui, Zheng Minying, Zhang Hao, Yang Xiaohui, Fan Linlin, Fu Fangmei, Fu Junjie, Niu Rui, Yan Man, Zhang Shiwu |
| 751684 |
FRONTIERS IN ONCOLOGY |
Development of Models to Predict Postoperative Complications for Hepatitis B Virus-Related Hepatocellular Carcinoma |
2021-10-05 |
10.3389/fonc.2021.717826 |
Bao Mingyang, Zhu Qiuyu, Aji Tuerganaili, Wei Shuyao, Tuergan Talaiti, Ha Xiaoqin, Tulahong Alimu, Hu Xiaoyi, Hu Yueqing |
| 751683 |
FRONTIERS IN ONCOLOGY |
β-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 Hyperactivation |
2021-10-05 |
10.3389/fonc.2021.747282 |
Zhao Wenxiu, Jiang Lingxiang, Fang Ting, Fang Fei, Liu Yingchun, Zhao Ye, You Yuting, Zhou Hao, Su Xiaolin, Wang Jiangwei, Liu Sheng, Chen Yaomin, Wan Jun, Huang Xiumei |
| 751682 |
FRONTIERS IN ONCOLOGY |
Detection of HPV and Human Chromosome Sites by Dual-Color Fluorescence In Situ Hybridization Reveals Recurrent HPV Integration Sites and Heterogeneity in Cervical Cancer |
2021-10-05 |
10.3389/fonc.2021.734758 |
Xiong Jinfeng, Cheng Jing, Shen Hui, Ren Ci, Wang Liming, Gao Chun, Zhu Tong, Li Xiaomin, Ding Wencheng, Zhu Da, Wang Hui |
| 751681 |
FRONTIERS IN ONCOLOGY |
Dynamic 18F-FDopa PET Imaging for Newly Diagnosed Gliomas: Is a Semiquantitative Model Sufficient? |
2021-10-05 |
10.3389/fonc.2021.735257 |
Zaragori Timothée, Doyen Matthieu, Rech Fabien, Blonski Marie, Taillandier Luc, Imbert Laëtitia, Verger Antoine |
| 751680 |
FRONTIERS IN ONCOLOGY |
Yttrium-90 TOF-PET-Based EUD Predicts Response Post Liver Radioembolizations Using Recommended Manufacturer FDG Reconstruction Parameters |
2021-10-05 |
10.3389/fonc.2021.592529 |
Hesse Michel, d’Abadie Philipe, Lhommel Renaud, Jamar Francois, Walrand Stephan |
| 751679 |
FRONTIERS IN ONCOLOGY |
MiR-873-5p: A Potential Molecular Marker for Cancer Diagnosis and Prognosis |
2021-10-05 |
10.3389/fonc.2021.743701 |
Zou Yuhao, Zhong Chenming, Hu Zekai, Duan Shiwei |
